The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of NewAmsterdam Pharma Company NV (NASDAQ: NAMS) closed at $26.61 in the last session, up 7.69% from day before closing price of $24.71. In other words, the price has increased by $7.69 from its previous closing price. On the day, 1.54 million shares were traded. NAMS stock price reached its highest trading level at $26.89 during the session, while it also had its lowest trading level at $24.4.
Ratios:
We take a closer look at NAMS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.61 and its Current Ratio is at 10.61. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On March 14, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $35.
On January 18, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $30.Guggenheim initiated its Buy rating on January 18, 2024, with a $30 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 12 ’24 when ForGrowth NAP B.V. sold 166,011 shares for $25.39 per share. The transaction valued at 4,215,827 led to the insider holds 11,150,461 shares of the business.
ForGrowth NAP B.V. sold 25,751 shares of NAMS for $644,048 on Dec 13 ’24. The 10% Owner now owns 11,124,710 shares after completing the transaction at $25.01 per share. On Dec 10 ’24, another insider, ForGrowth NAP B.V., who serves as the 10% Owner of the company, sold 308,250 shares for $25.37 each. As a result, the insider received 7,818,808 and left with 11,470,510 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NAMS now has a Market Capitalization of 2848680448 and an Enterprise Value of 1860631936. Its current Enterprise Value per Revenue stands at 55.386 whereas that against EBITDA is -10.109.
Stock Price History:
Over the past 52 weeks, NAMS has reached a high of $27.29, while it has fallen to a 52-week low of $10.12. The 50-Day Moving Average of the stock is 28.03%, while the 200-Day Moving Average is calculated to be 36.53%.
Shares Statistics:
According to the various share statistics, NAMS traded on average about 675.71K shares per day over the past 3-months and 1966790 shares per day over the past 10 days. A total of 92.17M shares are outstanding, with a floating share count of 44.65M. Insiders hold about 51.67% of the company’s shares, while institutions hold 41.33% stake in the company. Shares short for NAMS as of 1732838400 were 2588991 with a Short Ratio of 3.83, compared to 1730332800 on 718042. Therefore, it implies a Short% of Shares Outstanding of 2588991 and a Short% of Float of 4.66.
